Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05986838Recruiting
Randomised, open-label trial (3 arms), sponsored by Cairo University. Primary endpoint: Luteinizing Hormone/Follicle Stimulating Hormone Ratio. Started Aug 2023; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05986838.